Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Laparoscopic Or Open Ileocolic Resection

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT06972901Not ApplicableRecruiting

Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin

NCT04643496Completed

CRP Monitoring After ICR in CD Patients

NCT03846778Completed

Risk Factors of Complications After Ileocolic Resection for Crohn Disease According to the Comprehensive Complication Index

Showing all 3 trials

Research Network

Common Treatments

  • Laparoscopic Or Open Ileocolic Resection1
  • Early Faecal Calprotectin Dosage1

Active Sponsors

  • University Hospital, Montpellier2
  • University Hospital, Clermont-Ferrand1

Top Investigators

Related Conditions

  • Crohn Disease2
  • Postendoscopic Operative Reccurence1
  • Crohn Disease Cd1

Activity Timeline